Resistance developing in drug treatment for tropical skin disease

Dermal leishmaniasis is an ulcerous skin disease caused by a tropical parasite, all forms of which can be treated with the drug miltefosine. Researchers in India studied the responses of 86 patients treated with miltefosine over 18 months that indicated a developing parasitic resistance to the drug, supporting a growing evidence base showing the rise of miltefosine resistance.